FiberCell Systems

FiberCell Systems is a privately held biotechnology tools company specializing in perfusion-based hollow fiber bioreactor (HFBR) systems. Its core technology offers a histocentric, three-dimensional cell culture environment that supports high-density, continuous cell growth for months with minimal maintenance, addressing key limitations of traditional flask-based methods. The company primarily serves academic, government, and industrial researchers in sectors including monoclonal antibody production, recombinant protein expression, extracellular vesicle isolation, and antibiotic pharmacokinetic/pharmacodynamic (PK/PD) studies. Its business model is based on selling bioreactor cartridges, systems, and associated media, positioning it as an enabling platform provider rather than a therapeutic developer.

3D perfusion hollow fiber bioreactor systems that mimic the mammalian capillary bed to enable high-density, long-term, in-vivo-like cell culture for protein production, extracellular vesicle harvest, and co-cultivation.

FiberCell competes in the benchtop bioreactor segment against major life science tools companies (e.g., Sartorius, Thermo Fisher) offering stirred-tank and other perfusion systems. Its differentiation lies in the unique hollow fiber architecture, which offers superior product concentration and continuous culture capabilities for specific applications like exosome production.